Advances in systemic therapies for triple negative breast cancer.
Leon-Ferre RA, Goetz MP.
BMJ. 2023 May 30;381:e071674. doi: 10.1136/bmj-2022-071674.
Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma.
Wang F, Huang Q, Su H, Sun M, Wang Z, Chen Z, Zheng M, Chakroun RW, Monroe MK, Chen D, Wang Z, Gorelick N, Serra R, Wang H, Guan Y, Suk JS, Tyler B, Brem H, Hanes J, Cui H.
Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2204621120. doi: 10.1073/pnas.2204621120. Epub 2023 Apr 25.
Targeted Therapy and Immunotherapy for Melanoma in Japan.
Namikawa K, Yamazaki N.
Curr Treat Options Oncol. 2019 Jan 24;20(1):7. doi: 10.1007/s11864-019-0607-8.
Immunosurveillance in clinical cancer management.
Kroemer G, Chan TA, Eggermont AMM, Galluzzi L.
CA Cancer J Clin. 2024 Mar-Apr;74(2):187-202. doi: 10.3322/caac.21818. Epub 2023 Oct 25.
Current and Future Treatment Options in the Management of Stage III NSCLC.
Li Y, Juergens RA, Finley C, Swaminath A.
J Thorac Oncol. 2023 Nov;18(11):1478-1491. doi: 10.1016/j.jtho.2023.08.011. Epub 2023 Aug 11.
Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer.
Chen F, Li T, Zhang H, Saeed M, Liu X, Huang L, Wang X, Gao J, Hou B, Lai Y, Ding C, Xu Z, Xie Z, Luo M, Yu H.
Adv Mater. 2023 Mar;35(10):e2209910. doi: 10.1002/adma.202209910. Epub 2023 Jan 10.
Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer.
Wang JB, Gao YX, Ye YH, Zheng QL, Luo HY, Wang SH, Zhang T, Jin QW, Zheng CH, Li P, Lin JX, Chen QY, Cao LL, Yang YH, Huang CM, Xie JW.
Theranostics. 2024 May 5;14(7):2915-2933. doi: 10.7150/thno.93124. eCollection 2024.
The microbiome and hepatobiliary-pancreatic cancers.
Mima K, Nakagawa S, Sawayama H, Ishimoto T, Imai K, Iwatsuki M, Hashimoto D, Baba Y, Yamashita YI, Yoshida N, Chikamoto A, Baba H.
Cancer Lett. 2017 Aug 28;402:9-15. doi: 10.1016/j.canlet.2017.05.001. Epub 2017 May 17.
Impact of neoadjuvant immunotherapy on postoperative complications after surgery for rectal cancer.
Shou M, Habib DRS, Idrees K, Hawkins A, Ford M, Lee H, Khan B, Khan A.
J Surg Oncol. 2024 Aug;130(2):322-328. doi: 10.1002/jso.27694. Epub 2024 May 27.
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy.
Bai G, Chen X, Peng Y, Ji Y, Bie F, Liu Y, Yang Z, Gao S.
Thorac Cancer. 2024 May;15(14):1138-1148. doi: 10.1111/1759-7714.15297. Epub 2024 Apr 4.
